Nada Matougui

493 total citations
8 papers, 415 citations indexed

About

Nada Matougui is a scholar working on Molecular Biology, Microbiology and Food Science. According to data from OpenAlex, Nada Matougui has authored 8 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Microbiology and 4 papers in Food Science. Recurrent topics in Nada Matougui's work include Antimicrobial Peptides and Activities (6 papers), Lipid Membrane Structure and Behavior (5 papers) and Advanced Drug Delivery Systems (3 papers). Nada Matougui is often cited by papers focused on Antimicrobial Peptides and Activities (6 papers), Lipid Membrane Structure and Behavior (5 papers) and Advanced Drug Delivery Systems (3 papers). Nada Matougui collaborates with scholars based in France and Sweden. Nada Matougui's co-authors include Anita Umerska, Patrick Saulnier, Anne‐Claire Groo, Lovisa Ringstad, Helena Bysell, Viviane Cassisa, Lukas Boge, Matthieu Eveillard, Mina Davoudi and Martin Andersson and has published in prestigious journals such as International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics and International Journal of Nanomedicine.

In The Last Decade

Nada Matougui

8 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nada Matougui France 8 247 165 108 88 79 8 415
Mark Gontsarik Switzerland 13 280 1.1× 93 0.6× 45 0.4× 82 0.9× 156 2.0× 24 523
Victoria Oluwaseun Fasiku South Africa 10 130 0.5× 69 0.4× 82 0.8× 28 0.3× 79 1.0× 13 416
Santhni Subramaniam Australia 10 128 0.5× 56 0.3× 68 0.6× 24 0.3× 24 0.3× 16 330
Fernando G. Dupuy Argentina 13 299 1.2× 113 0.7× 16 0.1× 61 0.7× 74 0.9× 26 419
Ramesh Gannimani South Africa 12 137 0.6× 61 0.4× 113 1.0× 19 0.2× 115 1.5× 14 459
Nae‐Gyu Kang South Korea 11 112 0.5× 31 0.2× 76 0.7× 25 0.3× 42 0.5× 38 403
Jenniffer Cruz Colombia 7 389 1.6× 153 0.9× 18 0.2× 29 0.3× 52 0.7× 10 502
Humaira Ilyas India 9 199 0.8× 179 1.1× 12 0.1× 24 0.3× 50 0.6× 13 339
Zhao Dong China 7 122 0.5× 20 0.1× 223 2.1× 89 1.0× 22 0.3× 7 381
Rajesh Kuppusamy Australia 14 220 0.9× 222 1.3× 11 0.1× 31 0.4× 207 2.6× 44 520

Countries citing papers authored by Nada Matougui

Since Specialization
Citations

This map shows the geographic impact of Nada Matougui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Matougui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Matougui more than expected).

Fields of papers citing papers by Nada Matougui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nada Matougui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Matougui. The network helps show where Nada Matougui may publish in the future.

Co-authorship network of co-authors of Nada Matougui

This figure shows the co-authorship network connecting the top 25 collaborators of Nada Matougui. A scholar is included among the top collaborators of Nada Matougui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nada Matougui. Nada Matougui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Matougui, Nada, Anne‐Claire Groo, Anita Umerska, Viviane Cassisa, & Patrick Saulnier. (2019). A Comparison of Different Strategies for Antimicrobial Peptides Incorporation onto/into Lipid Nanocapsules. Nanomedicine. 14(13). 1647–1662. 22 indexed citations
2.
Groo, Anne‐Claire, Nada Matougui, Anita Umerska, & Patrick Saulnier. (2018). Reverse micelle-lipid nanocapsules: a novel strategy for drug delivery of the plectasin derivate AP138 antimicrobial peptide. International Journal of Nanomedicine. Volume 13. 7565–7574. 46 indexed citations
3.
Umerska, Anita, Magnus Strandh, Viviane Cassisa, et al.. (2018). Synergistic Effect of Combinations Containing EDTA and the Antimicrobial Peptide AA230, an Arenicin-3 Derivative, on Gram-Negative Bacteria. Biomolecules. 8(4). 122–122. 32 indexed citations
4.
Boge, Lukas, Anita Umerska, Nada Matougui, et al.. (2017). Cubosomes post-loaded with antimicrobial peptides: characterization, bactericidal effect and proteolytic stability. International Journal of Pharmaceutics. 526(1-2). 400–412. 96 indexed citations
5.
Umerska, Anita, Viviane Cassisa, Guillaume Bastiat, et al.. (2017). Synergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a cosurfactant against <em>Staphylococcus aureus</em>. International Journal of Nanomedicine. Volume 12. 5687–5699. 37 indexed citations
6.
Umerska, Anita, Nada Matougui, Anne‐Claire Groo, & Patrick Saulnier. (2016). Understanding the adsorption of salmon calcitonin, antimicrobial peptide AP114 and polymyxin B onto lipid nanocapsules. International Journal of Pharmaceutics. 506(1-2). 191–200. 36 indexed citations
7.
Matougui, Nada, Lukas Boge, Anne‐Claire Groo, et al.. (2016). Lipid-based nanoformulations for peptide delivery. International Journal of Pharmaceutics. 502(1-2). 80–97. 90 indexed citations
8.
Umerska, Anita, Viviane Cassisa, Nada Matougui, et al.. (2016). Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants. European Journal of Pharmaceutics and Biopharmaceutics. 108. 100–110. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026